Symbol
CTOR on Nasdaq
Investment type
Equity / Common stock, $0.0001 par value
Latest Disclosed Ownership
66M shares
Security Ownership
79.1%

Citius Pharmaceuticals, Inc. ownership in CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value (CTOR)

2025-09-12 - Citius Pharmaceuticals, Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 66M shares of CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value (CTOR). This represents 79.1% percent ownership of the company.